|
|
Article: Clinical Sciences receives FDA approval to market new diagnostic test for viral infection. (Clin-Elisa CMV IgM for detection of cytomegalovirus)
- Article from:
- PR Newswire
- Article date:
- April 12, 1988
CopyrightCOPYRIGHT 1988 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CLINICAL SCIENCES RECEIVES FDA APPROVAL TO MARKET
NEW DIAGNOSTIC TEST FOR VIRAL INFECTION
WHIPPANY, N.J., April 12 /PRNewswire/ -- Clinical Sciences Inc. (NASDAQ: CLSC), an affiliate of the FIAT Group, today announced it has received approval from the Food and Drug Administration to begin marketing a diagnostic test for the detection of cytomegalovirus (CMV). The test, Clin-Elisa CMV IgM, is a microplate Elisa test system, which detects the presence of IgM antibodies specific to CMV in human serum.
CMV is one of the more common causes of congenital viral infections and can result in serious illness and birth defects in ...